MENU
RNXT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
RenovoRx (RNXT) Ownership - Who owns RenovoRx?
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment... Show more
Profile
Industry
N/A
Address
4546 El Camino Real
Phone
+1 650 284-4433
Employees
8
Web
https://www.renovorx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
47.54M
P/E Ratio
N/A
Total Cash
14.58M
Projected Growth
N/A
Total Debt
283K
Revenue
240K
Risk (Beta)
1.00
Dividend Yield
N/A
Total Cash/Share
0.40
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price
Fundamentals
RNXT
Capitalization
47.5M
P/E Ratio
N/A
Risk (Beta)
1.00
Dividend Yield
N/A
Total Cash
14.6M
Total Cash/Share
0.40
Total Debt
283K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.01%
Revenue
240K
ROE
N/A
Book Value
13.2M
P/B Ratio
3.61
Cash Flow
N/A
Earnings
-0.41
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
4K
Current Ratio
9.07
Current Revenue Per Employee
19700.00
Dividends Per Share - Security
N/A
EBITDA
-11.6M
Float
N/A
Float - Current
N/A
Gross Income Margin
52.28
Revenue To Assets
-97.66
Shares Held By Institutions
10.3M
Shares Outstanding - Current
36.6M
Total Liabilities
2.86M
Total Volume MTD
N/A
Value
N/A
Gain YTD
0.775
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
4546 El Camino Real
Phone
+1 650 284-4433
Employees
8
Web
https://www.renovorx.com